The first Alnylam Pharmaceuticals trade was made in Q1 2014.
Since then Jim Simons bought shares six more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2018 and Q4 2018.
Avg closing price
Price range
Sold -64.4 Thousand shares
Q4 2018
Avg closing price
$76.92
Price range
$62.67
-
$88.33
Sold 82.8% shares (-311 Thousand shares)
Q3 2018
Avg closing price
$100.59
Price range
$87.52
-
$122.67
Increased shares by 59.5% (+140 Thousand shares)
Q2 2018
Avg closing price
$99.19
Price range
$88.31
-
$107.80
Increased shares by 2806.2% (+227 Thousand shares)
Q1 2018